Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Selskabsmeddelelse

MEDI: FIRST QUARTER FINANCIAL RESULTS 2023

Medistim
Sales for the first quarter ended at MNOK 129.3 (MNOK 116.1), an increase of
11.3%. The Vascular business segment continues the positive development and
grows at 21.5% in NOK, currency neutral 8.8% growth. The Imaging products grow
at 9.4% in NOK with a currency neutral decline of 3.7%. Currency neutral growth
of own products was 2.5%. Operating profit (EBIT) for the quarter ended at MNOK
33.5 (MNOK 33.4). Medistim establishes direct sales organizations in both Canada
and China this quarter. Cash position is down MNOK 3.3 due to inventory build up
and timing of sales for the quarter. The General Meeting decided a dividend of
NOK 4.50 per share, a total dividend payment of MNOK 82.2
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.